@ERSpublications New ERJ study adds to the evidence casting doubt on the utility of recommended cut-offs for sleep apnoea treatment http://ow.ly/VgjBLMost sleep clinicians and scientists will agree that if a patient with sleep apnoea is symptomatic and has an apnoea/hypopnea index (AHI) of more than 15 events per hour, he or she deserves treatment. However, there is a large group of patients with mild and moderate sleep apnoea who are asymptomatic. For these individuals, the decision of when to treat is a grey area, and current guidelines leave clinicians wondering what to do.ARNARDOTTIR et al.[1] from the University Hospital of Iceland studied a large general population sample of middle-aged individuals using polysomnographic sleep recordings, questionnaires and the psychomotor vigilance test (PVT). Of the 415 subjects, 12.5% had moderate obstructive sleep apnoea (OSA; AHI between 15 and 30), 2.9% had severe OSA (AHI ⩾30), and 3.6% were already diagnosed and treated for OSA. Interestingly, no relationship was found between AHI and subjective sleepiness or clinical symptoms, whereas a relationship with objective vigilance, as measured by the PVT, was found only with those with AHI ⩾30. Furthermore, subjects with moderate or severe OSA were not more likely to have cardiometabolic disease than subjects with no or mild OSA. These results raise the question of whether the current cut-off of AHI ⩾15 as a sole criterion is appropriate for diagnosis and treatment of OSA.In 1998, we first reported, using the Penn State Adult Cohort, a different frequency and pattern of prevalence of OSA based on AHI solely versus based on a combination of AHI and presence of clinical symptoms (i.e. sleepiness and/or cardiometabolic disorders) [2]. The prevalence of OSA based on AHI alone was two to three times the prevalence of OSA based on laboratory and clinical criteria. Furthermore, based on AHI alone, the prevalence of OSA increased linearly, reaching its peak at very old age, whereas the prevalence based on combined criteria peaked at the age of 55 years for men and 65 years for women, then declined steeply ( figure 1) [2, 3]. In addition, oxygen desaturation in older individuals was significantly less compared to that in younger individuals, suggesting the possibility that OSA in the elderly is less severe. Together, these findings suggested that the sleep field should re-evaluate the current criteria for diagnosis and treatment in this age group. These early observations were further strengthened by another report in the same large cohort on the association of hypertension and OSA. We reported that AHI, controlled for relevant confounding variables, was independently associated with hypertension [4]. In addition, this study confirmed that the strength of the association between AHI and blood pressure was strongest in the youngest (figure 2). These findings further supported the implication that OSA in older individuals is not an independent risk factor for hypertension.